Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recommendations for in-clinic PoCT for diabetes management in India.
Saboo B, Sadikot S, Prasanna Kumar KM, Joshi S, Aravind SR, Makkar BM, Chawla R, Kesavadev J, Chawla M, Kovil R, Shah T, Mohit M, Vyas C, Dhandhania VK. Saboo B, et al. Among authors: chawla r, chawla m. Diabetes Metab Syndr. 2019 Jan-Feb;13(1):5-7. doi: 10.1016/j.dsx.2018.05.005. Epub 2018 May 8. Diabetes Metab Syndr. 2019. PMID: 30641753
Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force.
Kalra S, Das AK, Sahay RK, Baruah MP, Tiwaskar M, Das S, Chatterjee S, Saboo B, Bantwal G, Bhattacharya S, Priya G, Chawla M, Brar K, Raza SA, Aamir AH, Shrestha D, Somasundaram N, Katulanda P, Afsana F, Selim S, Naseri MW, Latheef A, Sumanatilleke M. Kalra S, et al. Among authors: chawla m. Diabetes Ther. 2019 Oct;10(5):1645-1717. doi: 10.1007/s13300-019-0669-4. Epub 2019 Jul 29. Diabetes Ther. 2019. PMID: 31359367 Free PMC article. Review.
Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial.
Dharmalingam M, Aravind SR, Thacker H, Paramesh S, Mohan B, Chawla M, Asirvatham A, Goyal R, Shembalkar J, Balamurugan R, Kadam P, Alva H, Kodgule R, Tandon M, Vaidyanathan S, Pendse A, Gaikwad R, Katare S, Suryawanshi S, Barkate H. Dharmalingam M, et al. Among authors: chawla m. Drugs. 2020 Apr;80(6):587-600. doi: 10.1007/s40265-020-01285-0. Drugs. 2020. PMID: 32162274 Free PMC article. Clinical Trial.
Suboptimal glycemic control among subjects with diabetes mellitus in India: a subset analysis of cross-sectional wave-7 (2016) data from the International Diabetes Management Practices Study (IDMPS).
Ramachandran A, Jain SM, Mukherjee S, Phatak S, Pitale S, Singh SK, Agrawal N, Majumdar A, Deshpande N, Jhulka S, Minakshisundaram S, Chawla M, Lodha S, Maheshwari A, Makkar BM, Rao S, Shah P, Ghosh R, Mohanasundaram S, Menon S, Chodankar D, Kanade V, Trivedi C. Ramachandran A, et al. Among authors: chawla m. Ther Adv Endocrinol Metab. 2020 Jun 27;11:2042018820937217. doi: 10.1177/2042018820937217. eCollection 2020. Ther Adv Endocrinol Metab. 2020. PMID: 32647562 Free PMC article.
Patient reported changes in metabolic health during lockdown: A cross sectional digital connect survey in people with type 2 diabetes.
Kovil R, Shah T, Chawla M, Karkhanis S, Padhye D, Sanghvi A, Kale MC, Chawla P, Prabhu N, Dhandhania V, Shah K, Sachdev M, Methil V, Tanna S, Nayak K, Bagri S, Patil P, Gandhi A, Aversekar S, Maheshwari R, Kothari A, Dhope R, Mehta A; RACE Indian Author group. Kovil R, et al. Among authors: chawla p, chawla m. Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1907-1912. doi: 10.1016/j.dsx.2020.09.031. Epub 2020 Sep 28. Diabetes Metab Syndr. 2020. PMID: 33011498 Free PMC article.
337 results